MedTrace Logo

Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis

NCT07111416 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2025-08-08

No results posted yet for this study

Summary

The goal of this observational study is to learn why some adults over the age of 65, have A1c tests that do not match up with their blood glucose levels, also known as 'A1c-glucose discordance'.

The main question it aims to answer is:

Could alternative tests like CGM or personalized A1c provide more accurate diabetes screening in this population?

Participants will be asked to perform blood tests every week to two weeks and wear a CGM for up to 8 weeks.

Conditions

Sponsors & Collaborators

  • Abbott Diabetes Care

    collaborator INDUSTRY

  • Brigham and Women's Hospital

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-04-01
Completion
2026-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111416 on ClinicalTrials.gov